Cost-utility analysis of recombinant human erythropoietin in anemic cancer patients induced by chemotherapy in Thailand. [electronic resource]
- Journal of the Medical Association of Thailand = Chotmaihet thangphaet Jun 2008
- S119-25 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
0125-2208
Anemia--chemically induced Antineoplastic Agents--adverse effects Blood Transfusion Cost-Benefit Analysis Erythropoietin--economics Humans Markov Chains Neoplasms--complications Probability Quality-Adjusted Life Years Recombinant Proteins Thailand